Pharmacy automation, 340B compliance, and medication management company Omnicell is acquiring ReCept Holdings, which helps hospitals, health centers, Ryan White Clinics, and other providers open and manage in-house 340B pharmacies and specialty pharmacies.
Mountain View, Calif.-based Omnicell (a 340B Report sponsor) last week said in a news release it had agreed to acquire ReCept “for total aggregate cash consideration of $100 million, subject to customary adjustments.” Last year, Omnicell paid $225 million to acquire Pharmaceutical Strategies Group’s 340B third party administrator (TPA) suite of services.
Omnicell said ReCept’s specialty pharmacy services and expertise will complement Omnicell 340B, the company’s 340B TPA line of business. The purchase “is expected to provide meaningful differentiation in the large and growing specialty pharmacy managed services organizations,” Omnicell said.
“The ReCept acquisition will add solutions for specialty pharmacy management services, including specialty pharmacy expertise and operational capabilities, human resources, technology and integration, workflow management, payor access assistance, and other aspects of managing a specialty pharmacy, to Omnicell’s broader medication management infrastructure,” Omnicell said.
“This total solution for provider groups, federally qualified health centers (FQHCs), and health systems supports on-site management of specialty pharmacy services, including payor contracting, staffing, licensing, quality assurance, 340B administration, and preferred pricing agreements designed to improve margin and profitability, while keeping the patient at the center of care.”